Patents by Inventor Sven Anders Wallqvist

Sven Anders Wallqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11371097
    Abstract: Disclosed are methods and articles (e.g., gene arrays or antibodies) for determining the progression or regression of liver fibrosis, for the diagnosis of liver disease, and for screening compounds for hepatotoxicity and efficacy against liver fibrosis. Related therapeutic methods also are disclosed.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: June 28, 2022
    Assignee: The Government of the United States, as represented by the Secretary of the Army
    Inventors: Mohamed Diwan M. Abdulhameed, Gregory J. Tawa, Danielle L. Ippolito, John A. Lewis, Sven Anders Wallqvist, Jonathan D. Stallings, Matthew G. Permenter
  • Patent number: 11345653
    Abstract: The invention relates to compounds, compositions and methods for activating, reactivating, reversing or preventing the deactivation of cholinesterases, such as acetylcholinesterase and butyrylcholinesterase.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 31, 2022
    Assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., The Government of the United States as Represented by the Secretary of the Army
    Inventors: Ilja Khavrutskii, Sven Anders Wallqvist